LI
GILD icon

LRI Investments’s Gilead Sciences GILD Stock Holding History

LRI Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255K Sell
2,017
-506
-20% -$66.7K 0.02% 284
2026
Q1 		$352K Buy
2,523
+755
+43% +$106K 0.03% 217
2025
Q4 		$217K Buy
1,768
+146
+9% +$17.7K 0.02% 269
2025
Q3 		$180K Buy
1,622
+144
+10% +$16.4K 0.01% 310
2025
Q2 		$164K Buy
1,478
+138
+10% +$14.7K 0.01% 328
2025
Q1 		$150K Buy
1,340
+529
+65% +$54.6K 0.01% 319
2024
Q4 		$75K Hold
811
– – 0.01% 465
2024
Q3 		$74.7K Buy
811
+603
+290% +$46K 0.01% 463
2024
Q2 		$14.2K Hold
208
– – ﹤0.01% 676
2024
Q1 		$15.2K Buy
+208
New +$16K ﹤0.01% 421

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

LRI Investments's GILD Position: Q2 2026 in Review

LRI Investments reduced its Gilead Sciences (GILD) stake by 20% in Q2 2026, selling an estimated $66.7K and leaving 2,017 shares worth $255K. The position accounts for 0.02% of the portfolio, ranked #284.

LRI Investments first reported a position in GILD in Q1 2024 and has held it in 10 quarters since. The position peaked at $352K in Q1 2026. 1,027 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • LRI Investments held 2,017 shares of Gilead Sciences worth $255K as of Q2 2026.
  • LRI Investments sold 506 Gilead Sciences shares in Q2 2026, an estimated $66.7K.
  • Gilead Sciences made up 0.02% of LRI Investments's portfolio in Q2 2026, its #284 holding.
  • LRI Investments first reported a position in Gilead Sciences in Q1 2024 and has held it in 10 quarters since.
  • LRI Investments's Gilead Sciences position peaked at $352K in Q1 2026.
  • 1,027 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.